Deciphera Pharmaceuticals Inc expected to post a loss of 91  cents a share - Earnings Preview

Deciphera Pharmaceuticals

29/04/2022 12:28

* Deciphera Pharmaceuticals Inc  DCPH.OQ   DCPH.O  is
expected
to show a rise in quarterly revenue when it reports  results on
May 2 (estimated). 
    * The Waltham Massachusetts-based  company is expected to
report 
a 3.8% increase in revenue to $26.105 million from $25.16
million a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Deciphera
Pharmaceuticals
Inc is for a loss of 91 cents per share. For the same quarter
last year, the company reported a loss of $1.06 per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 6
"hold" and 2 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $11​, above​ its last closing price
of $10.83. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -1.49       -1.38      -1.51     Missed  -9.5
 Sep. 30 2021  -1.27       -1.28      -1.37     Missed  -7.4
 Jun. 30 2021  -1.16       -1.15      -1.21     Missed  -4.8​
 Mar. 31 2021  -1.07       -1.06      -1.06     Met     0.3
 ​​Dec.        -1.15       -1.15      -1.10     Beat    4.5
 31 2020                                                
 Sep. 30 2020  -1.31       -1.30      -1.13     Beat    13​
 Jun. 30 2020  -1.38       -1.37      -1.20     Beat    12.2
 Mar. 31 2020  -1.29       -1.25      -1.36     Missed  -8.4
 This summary was machine generated April 29 at 11:28 GMT.  All
figures in US dollars  unless otherwise stated